World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
77
Citations
22095
World Ranking
1348
National Ranking
590

Overview

Paolo Lusso is affiliated with the National Institutes of Health in the United States. Their research primarily focuses on the fields of Medicine and Immunology and Microbiology, contributing to an extensive body of work in related subfields such as Infectious Diseases, Virology, Immunology, Radiology, Nuclear Medicine and Imaging, and Epidemiology.

Their work covers several main topics, including HIV Research and Treatment, SARS-CoV-2 and COVID-19 Research, Monoclonal and Polyclonal Antibodies Research, Immune Cell Function and Interaction, Respiratory Viral Infections Research, COVID-19 Clinical Research Studies, and HIV/AIDS Drug Development and Treatment.

Paolo Lusso has authored multiple papers, some notable recent publications include:

  • A multiclade env-gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaques (2021) published in Nature Medicine
  • Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in monkeys (2022) published in Cell
  • HIV vaccine delayed boosting increases Env variable region 2-specific antibody effector functions (2020) published in JCI Insight
  • Anti-PF4 antibodies associated with disease severity in COVID-19 (2022) published in Proceedings of the National Academy of Sciences
  • A matrix of structure-based designs yields improved VRC01-class antibodies for HIV-1 therapy and prevention (2021) published in mAbs

They have collaborated frequently with co-authors including Qingbo Liu, Huiyi Miao, Peng Zhang, Yumiko Matsuoka, and Celia Santos.

Paolo Lusso's research has been published in several recurring venues such as bioRxiv (Cold Spring Harbor Laboratory), Proceedings of the National Academy of Sciences, mAbs, Cell Reports, and mBio.

Best Publications

  • Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8+ T Cells

    Fiorenza Cocchi;Anthony L. DeVico;Alfredo Garzino-Demo;Suresh K. Arya

  • In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression.

    Gabriella Scarlatti;Eleonora Tresoldi;Åsa Björndal;Robert Fredriksson

  • The V3 domain of the HIV–1 gp120 envelope glycoprotein is critical for chemokine–mediated blockade of infection

    Florenza Cocchi;Anthony L. DeVico;Alfredo Garzino-Demo;Andrea Cara

  • CD46 is a cellular receptor for human herpesvirus 6.

    Fabio Santoro;Paul E Kennedy;Giuseppe Locatelli;Mauro S Malnati

  • Chromosomally integrated human herpesvirus 6: questions and answers

    Philip E. Pellett;Dharam V. Ablashi;Peter F. Ambros;Henri Agut

  • In vitro cellular tropism of human B-lymphotropic virus (human herpesvirus-6).

    P Lusso;P D Markham;E Tschachler;F di Marzo Veronese

  • Classification of HHV-6A and HHV-6B as distinct viruses.

    Dharam Ablashi;Henri Agut;Roberto Alvarez-Lafuente;Duncan A. Clark

  • Productive dual infection of human CD4+ T lymphocytes by HIV-1 and HHV-6.

    Paolo Lusso;Barbara Ensoli;Phillip D. Markham;Dharam V. Ablashi

  • Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1.

    P. Lusso;F. Cocchi;C. Balotta;P. D. Markham

  • Detection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction.

    Paola Secchiero;Donald R. Carrigan;Yoshizo Asano;Laura Benedetti

  • Induction of CD4 and susceptibility to HIV-1 infection in human CD8+ T lymphocytes by human herpesvirus 6.

    Paolo Lusso;Andrea De Maria;Mauro Malnati;Franco Lori

  • HIV and the chemokine system: 10 years later.

    Paolo Lusso

  • Cryptic nature of envelope V3 region epitopes protects primary monocytotropic human immunodeficiency virus type 1 from antibody neutralization.

    Dumit H Chequer Bou-Habib;G. Roderiquez;T. Oravecz;P. W. Berman

  • Multiple Antiviral Activities of Cyanovirin-N: Blocking of Human Immunodeficiency Virus Type 1 gp120 Interaction with CD4 and Coreceptor and Inhibition of Diverse Enveloped Viruses

    Barna Dey;Danica L. Lerner;Paolo Lusso;Michael R. Boyd

  • CD4 is a critical component of the receptor for human herpesvirus 7: interference with human immunodeficiency virus

    Paolo Lusso;Paola Secchiero;Richard W. Crowley;Alfredo Garzino-Demo

  • Rational design of a CD4 mimic that inhibits HIV-1 entry and exposes cryptic neutralization epitopes

    Loïc Martin;François Stricher;Dorothée Missé;Francesca Sironi

  • Viral DNA carried by human immunodeficiency virus type 1 virions.

    F Lori;F di Marzo Veronese;A L de Vico;P Lusso

  • Additional evidence that pityriasis rosea is associated with reactivation of human herpesvirus-6 and -7.

    Francesco Broccolo;Francesco Drago;Anna M. Careddu;Chiara Foglieni

  • Infection of natural killer cells by human herpesvirus 6.

    Paolo Lusso;Mauro S. Malnati;Alfredo Garzino-Demo;Richard W. Crowley

  • HBLV (or HHV-6) in human cell lines.

    D.V. Ablashi;S.Z. Salahuddin;S.F. Josephs;F. Imam

Frequent Co-Authors

Robert C. Gallo
Robert C. Gallo University of South Florida
Mauro S. Malnati
Mauro S. Malnati Vita-Salute San Raffaele University
Phillip D. Markham
Phillip D. Markham Northrop Grumman (United States)
Edward A. Berger
Edward A. Berger National Institutes of Health
Peter D. Kwong
Peter D. Kwong Columbia University Medical Center
Simona Polo
Simona Polo University of Milan
Dharam V. Ablashi
Dharam V. Ablashi Georgetown University
Brian F. Volkman
Brian F. Volkman Medical College of Wisconsin
Anthony S. Fauci
Anthony S. Fauci Georgetown University
Anthony L. DeVico
Anthony L. DeVico University of Maryland, Baltimore

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring the field of Microbiology opens up diverse career pathways, many of which can be pursued through online degrees. For those interested in healthcare, understanding what medical degrees can I get online is essential. These programs offer flexibility while preparing students for roles in clinical research, diagnostics, and public health.

Public health is closely linked with microbiology, and enrolling in easy admission online MPH programs can be a strategic move. These programs provide foundational knowledge about disease control and epidemiology, making them accessible options for students from various backgrounds.

For individuals drawn to working with children in healthcare settings, becoming a certified child life specialist is a rewarding career. Understanding the certified child life specialist salary and required qualifications helps in making informed decisions about this path.

It’s important to recognize that many online degrees are designed to be inclusive. Learning about what is the best degree for a convicted felon can help those with past convictions find suitable educational opportunities and build promising careers in microbiology-related fields.

Best Scientists Citing Paolo Lusso

Trending Scientists